特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
969807

スペインのコンシューマーヘルス製品市場

Consumer Health in Spain

出版日: | 発行: Euromonitor International | ページ情報: 英文 117 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
スペインのコンシューマーヘルス製品市場
出版日: 2020年11月05日
発行: Euromonitor International
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

新型コロナウイルス感染症 (COVID-19) の世界的流行はスペインの社会と経済に衝撃を与え、コンシューマーヘルス製品の市場にも大きな影響を及ぼしています。

当レポートでは、スペインのコンシューマーヘルス製品の市場を調査し、製品・カテゴリー別の売上の推移・予測、企業およびブランドのシェア、新型コロナウイルス感染症 (COVID-19) の影響、回復の見通しと市場機会、将来の展望などをまとめています。

調査内容

  • エグゼクティブサマリー
    • COVID-19:市場への影響
    • COVID-19:国への影響
    • 企業の対応、など
  • 市場指標
  • 市場データ
    • 売上の推移・予測:カテゴリー別
    • 企業シェア
    • ブランドシェア
    • 流通動向:形態・カテゴリー別
  • 世界のマクロ経済環境
  • 世界の産業環境
  • 市場分析:カテゴリー・製品別
    • 鎮痛薬
    • 風邪薬・アレルギー薬
    • 消化薬
    • 皮膚病薬
    • 睡眠補助薬
    • アイケア製品
    • 創傷治療製品
    • ビタミン剤
    • 栄養補助食品
    • 体重管理・ウェルビーイング製品
    • スポーツ栄養
    • 植物薬・伝統薬
    • 小児向け製品
      • 2020年の影響
      • 回復の見通し・市場機会
      • 売上の推移・予測
      • 企業シェア
      • ブランドシェア
目次
Product Code: CHES

The outbreak of Coronavirus (COVID-19) has provided a shock to both the Spanish economy and society and significantly impacted consumer health sales. While Spain has not suffered from obvious shortages of medicines, the stockpiling of certain products, especially analgesics and cough, cold and allergy (hay fever) remedies, has been observed. Perceived to offer immunity/resistance to the symptoms of COVID-19, analgesics and cough, cold and allergy (hay fever) remedies have emerged as strong winne...

Euromonitor International's Consumer Health in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

TABLE OF CONTENTS

List OF CONTENTS AND TABLES

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 2 Life Expectancy at Birth 2015-2020

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2015-2020
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
  • Table 8 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

    • Summary 1 Research Sources

KEY DATA FINDINGS

2020 IMPACT

Perceived immunity/protection from Coronavirus (COVID-19) symptoms boosts sales of analgesics

Acceleration of healthier lifestyles trend as lockdown eases boosts topical analgesics/anaesthetic

Limited movement in company/brand shares or rankings as consumers seek familiarity at a time of crisis

RECOVERY AND OPPORTUNITIES

Lingering COVID-19 pandemic and fitness and demographic trends set to influence category performance in the forecast period

De-listing medicines like 1g paracetamol and 650g ibuprofen may stimulate OTC sales

Competition from cheaper reimbursed generics set to limit OTC sales growth

CATEGORY DATA

  • Table 12 Sales of Analgesics by Category: Value 2015-2020
  • Table 13 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 14 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 15 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 16 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Coronavirus (COVID-19) boosts sales as products seen as offering possible immunity/protection from the virus

Milder, drier climate offers opportunities for allergy products, but new Rx treatments likely to dampen growth potential

Johnson rides the popularity of Frenadol to consolidate leading position, although novelties are placed on the backburner during COVID-19

RECOVERY AND OPPORTUNITIES

Flu seasons expected to shape performance, but lingering COVID-19 crisis and climate change set to play strong role in short to medium term

Stronger controls on dosages without prescriptions may see shift from OTC to Rx products

Increasingly informed and health-conscious consumers likely to push launches of more natural products

CATEGORY DATA

  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Lockdown's limits on exercise and effect on dietary habits benefit some digestive remedies, although travel restrictions hinder diarrhoeal and motion sickness remedies

Proton pump indicators benefits from positioning as substitute for ranitidine medicines following health scare in H2 blockers

Almirall leads through trusted product range and strong marketing, although small producer laboratories remain highly important

RECOVERY AND OPPORTUNITIES

Lingering pandemic provides fertile ground for mild digestive problems and the use of OTC remedies

Increasingly proactive approach to consumer health may favour probiotics other regular digestive remedies

Incentives for doctors and pharmacies and economic difficulties may see generics emerge in digestive remedies

CATEGORY DATA

  • Table 24 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 25 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 26 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 27 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 28 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Topical antiseptics benefits from Coronavirus (COVID-19) as hygiene awareness heightens, while preference for outdoor exercise as lockdown eases supports need for germicidals

Closure of schools reduces incidence of parasite infections and hits sales of antiparasitics/lice (head and body) treatments

Large presence of small local laboratories influences high fragmentation of competitive landscape

RECOVERY AND OPPORTUNITIES

COVID-19's ongoing impact on hygiene, exercise and education norms and demographic trends set to influence sales in the forecast period

More natural products offer growth potential as consumers look for safer and kinder products for their skin

Companies need to invest in innovation and marketing to resist encroachment by hair care players

CATEGORY DATA

  • Table 30 Sales of Dermatologicals by Category: Value 2015-2020
  • Table 31 Sales of Dermatologicals by Category: % Value Growth 2015-2020
  • Table 32 NBO Company Shares of Dermatologicals: % Value 2016-2020
  • Table 33 LBN Brand Shares of Dermatologicals: % Value 2017-2020
  • Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
  • Table 35 Forecast Sales of Dermatologicals by Category: Value 2020-2025
  • Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Possible links between nicotine and Coronavirus (COVID-19) symptoms depress the demand for NRT smoking cessation aids

Legislation on reimbursed alternatives hits the demand for NRT smoking cessation aids

Johnson & Johnson adapts its activities to support the fight against COVID-19 while investing in marketing to pique the interest of consumers

RECOVERY AND OPPORTUNITIES

Further sales declines anticipated as reimbursed alternatives and COVID-19 economic and health effects hinder demand

Stronger healthier lifestyle trend in the wake of COVID-19 offers some optimism for NRT smoking cessation aids

Importance of marketing and strong brand equity leave little room for private label or generics

CATEGORY DATA

  • Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
  • Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
  • Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
  • Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Higher demand for sleep aids as Coronavirus (COVID-19) exacerbates stress and anxiety levels among the population

COVID-19 measures increase interaction via technological devices and incidence of sleep disorders

High presence of small laboratories producing more natural options ensures dominant retail value share for "others"

RECOVERY AND OPPORTUNITIES

Economic and lifestyle trends set to retain strong demand for sleep aids in the forecast period

Strong category performance is set to encourage innovation and new product launches in the short to medium term

Search for more natural and milder sleep remedies provides room for growth for herbal/traditional products

CATEGORY DATA

  • Table 43 Sales of Sleep Aids: Value 2015-2020
  • Table 44 Sales of Sleep Aids: % Value Growth 2015-2020
  • Table 45 NBO Company Shares of Sleep Aids: % Value 2016-2020
  • Table 46 LBN Brand Shares of Sleep Aids: % Value 2017-2020
  • Table 47 Forecast Sales of Sleep Aids: Value 2020-2025
  • Table 48 Forecast Sales of Sleep Aids: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Lockdown forces consumers to spend longer hours at home, leading to higher exposure to technological device screens and eye-related problems

Ageing population trend offers growth opportunities through age-segmented and age-specific product ranges and formats

Professional recommendations consolidate Thea Pharma's leadership of eye care

RECOVERY AND OPPORTUNITIES

Lingering health and economic effects of COVID-19 offer growth potential for eye care

Ageing population trend and high use of electronic devices predicted to grow the need for eye care products

Eye care set to see growing competition from advanced contact lenses with technology to reduce dry eye problems when using electronic devices

CATEGORY DATA

  • Table 49 Sales of Eye Care by Category: Value 2015-2020
  • Table 50 Sales of Eye Care by Category: % Value Growth 2015-2020
  • Table 51 NBO Company Shares of Eye Care: % Value 2016-2020
  • Table 52 LBN Brand Shares of Eye Care: % Value 2017-2020
  • Table 53 Forecast Sales of Eye Care by Category: Value 2020-2025
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Opportunities for sport and other outdoor activities sustain need for wound care during Coronavirus (COVID-19)

Strong economic impact of COVID-19 deters investment in new products in 2020

Private label is the winner as consumers turn to cheaper wound care products in an economically depressed market

RECOVERY AND OPPORTUNITIES

Greater participation in sport and exercise as part of the healthier lifestyle trend is set to boost sales of wound care

Ageing and more active population trends set to support demand for various wound care needs

Added-value products and features offer competitive tools for branded players to resist private label encroachment

CATEGORY DATA

  • Table 55 Sales of Wound Care by Category: Value 2015-2020
  • Table 56 Sales of Wound Care by Category: % Value Growth 2015-2020
  • Table 57 NBO Company Shares of Wound Care: % Value 2016-2020
  • Table 58 LBN Brand Shares of Wound Care: % Value 2017-2020
  • Table 59 Forecast Sales of Wound Care by Category: Value 2020-2025
  • Table 60 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Consumers increase their consumption of vitamins to strengthen their resistance to Coronavirus (COVID-19)

Multivitamins and vitamin D benefit from high demand from women looking to cope with pregnancy and general calcium needs

COVID-19 hampers new product development and affects modes of distribution

RECOVERY AND OPPORTUNITIES

COVID-19 and other established drivers set to stimulate regular use of vitamins over the forecast period

Limited approval of vitamin intake from Spanish doctors set to hinder the growth potential of the category

Holistic approach to health and wellbeing offers more opportunities for the regular intake of vitamins

CATEGORY DATA

  • Table 61 Sales of Vitamins by Category: Value 2015-2020
  • Table 62 Sales of Vitamins by Category: % Value Growth 2015-2020
  • Table 63 Sales of Multivitamins by Positioning: % Value 2015-2020
  • Table 64 NBO Company Shares of Vitamins: % Value 2016-2020
  • Table 65 LBN Brand Shares of Vitamins: % Value 2017-2020
  • Table 66 Forecast Sales of Vitamins by Category: Value 2020-2025
  • Table 67 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Coronavirus (COVID-19) outbreak enhances demand for products with immunity/resistance potential

Beauty and sports trends offer potential growth mine for dietary supplements

Idiosyncrasy of Spanish pharmaceutical industry sees small local companies exert a strong influence on dietary supplements

RECOVERY AND OPPORTUNITIES

The ongoing COVID-19 crisis and shift to a preventative health approach offer strong growth potential for dietary supplements

Health positioning expected to boost awareness and sales of dietary supplements

Life-stage needs and lifestyle trends set to spike interest in dietary supplements among Spanish women

CATEGORY DATA

  • Table 68 Sales of Dietary Supplements by Category: Value 2015-2020
  • Table 69 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
  • Table 70 Sales of Dietary Supplements by Positioning: % Value 2015-2020
  • Table 71 NBO Company Shares of Dietary Supplements: % Value 2016-2020
  • Table 72 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
  • Table 73 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
  • Table 74 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Outbreak of Coronavirus (COVID-19) derails peak sales season for weight management and wellbeing

Renewed appreciation of the outdoors during COVID-19 adds dynamism to category demand

COVID-19 places innovation on the backburner and forces direct sellers to shift to e-commerce to sustain sales

RECOVERY AND OPPORTUNITIES

Healthier lifestyle trend set to sustain interest despite lingering threat to sales peaks from COVID-19 and combination methods

Growing range of alternatives threatens use and growth potential of weight management and wellbeing

Positive growth signs as some consumers aim to achieve their desired appearance with the least effort

CATEGORY DATA

  • Table 75 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
  • Table 76 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
  • Table 77 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
  • Table 78 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
  • Table 79 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Coronavirus (COVID-19) closure of indoor sports and fitness centres damages marketing and sales of sports nutrition

Exercise regimes and broader healthy living trend help to sustain a demand for sports nutrition during COVID-19

COVID-19's stay-at-home measures and economic effects consolidate the strength of e-commerce in sports nutrition

RECOVERY AND OPPORTUNITIES

Quick return to positive growth anticipated as the potential consumer base grows for sports nutrition

A wider, more heterogeneous consumer base and economic concerns offer opportunities for lower-cost ranges

Sustainability, transparency and product origin are set to play key roles in labelling and purchasing decisions in the forecast period

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition by Category: Value 2015-2020
  • Table 82 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
  • Table 83 NBO Company Shares of Sports Nutrition: % Value 2016-2020
  • Table 84 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
  • Table 85 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
  • Table 86 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Herbal/traditional sleep aids sees fastest sales growth as Coronavirus (COVID-19) crisis disturbs sleeping patterns

Growing consumer awareness of ingredients and potential side effects of chemicals shifts focus to herbal/traditional products

Uriach-Aquilea gains leading position through brands in categories benefiting from COVID-19 effects

RECOVERY AND OPPORTUNITIES

Ongoing threat and effects of COVID-19 and shift to milder, more natural options offer bright outlook for herbal/traditional products

General focus on authentic and sustainable ingredients creates space for all-natural formulas in consumer health as in other industries

Growth potential in herbal/traditional products set to entice newcomers, while economic recession offers opportunities for stronger private label presence

CATEGORY DATA

  • Table 87 Sales of Herbal/Traditional Products by Category: Value 2015-2020
  • Table 88 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
  • Table 89 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
  • Table 90 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
  • Table 91 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

The category is mainly shaped by pre-Coronavirus (COVID-19) factors, although the pandemic stimulates growth in certain categories

Falling birth rate shrinks consumer base although higher health awareness and less pressure on family budgets continue to stimulate growth

Cheaper generics recommended by paediatricians increase the pressure on branded companies in the wake of COVID-19

RECOVERY AND OPPORTUNITIES

Pre-COVID-19 factors set to continue to shape performance over the forecast period

Fierce economic recession may stimulate de-reimbursement of paediatric ranges, thereby supporting category sales

Rising health awareness, smaller family sizes and lifestyle problems may spur spending on paediatric consumer health products

CATEGORY DATA

  • Table 93 Sales of Paediatric Consumer Health by Category: Value 2015-2020
  • Table 94 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
  • Table 95 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
  • Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
  • Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
  • Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.